OncoVerity Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $14M

  • Investors
  • 4

OncoVerity General Information

Description

Operator of a biotechnology firm intended to develop targeted therapies for cancer. The company uses computational tools for clinical and biological data to create drugs that specifically target cancer cells, enabling doctors with an effective and safer alternative to traditional treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States
+1 (720)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 12635 East Montview Boulevard
  • Aurora, CO 80045
  • United States
+1 (720)

OncoVerity Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoVerity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A1) 10-Dec-2024 $14M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 27-Mar-2023 Completed Clinical Trials - Phase 2
To view OncoVerity’s complete valuation and funding history, request access »

OncoVerity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view OncoVerity’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OncoVerity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology firm intended to develop targeted therapies for cancer. The company uses computational tools
Drug Discovery
Aurora, CO

Santa Monica, CA
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoVerity Competitors (2)

One of OncoVerity’s 2 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 2 of 2 competitors. Get the full list »

OncoVerity Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Argenx Corporation Minority
CU Healthcare Innovation Fund Corporate Venture Capital Minority
RefinedScience Corporation Minority
University of Colorado Health University Minority
To view OncoVerity’s complete investors history, request access »

OncoVerity FAQs

  • When was OncoVerity founded?

    OncoVerity was founded in 2022.

  • Where is OncoVerity headquartered?

    OncoVerity is headquartered in Aurora, CO.

  • What industry is OncoVerity in?

    OncoVerity’s primary industry is Drug Discovery.

  • Is OncoVerity a private or public company?

    OncoVerity is a Private company.

  • What is the current valuation of OncoVerity?

    The current valuation of OncoVerity is .

  • What is OncoVerity’s current revenue?

    The current revenue for OncoVerity is .

  • How much funding has OncoVerity raised over time?

    OncoVerity has raised $44M.

  • Who are OncoVerity’s investors?

    Argenx, CU Healthcare Innovation Fund, RefinedScience, and University of Colorado Health have invested in OncoVerity.

  • Who are OncoVerity’s competitors?

    Kite Pharma and Genetix Biotherapeutics are competitors of OncoVerity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process